Add more content here...

ESHO 2019

22-25 May 2019

Offizielle Website der ESHO

Vom 22. bis 24. Mai fand das 33. jährliche Treffen der European Society for Hyperthermic Oncology in Warschau statt. Auch Oncotherm war auf der Konferenz vertreten.
Es gab über 50 Präsentationen zum Thema Hyperthermie, im Folgenden sind die aufgelistet, die Oncothermie im Speziellen behandelt haben:


  1. A. Szasz: Immune-effects with local hyperthermia
  2. S. Van Gool: Can we monitor Immunogenic Cell Death (ICD) induced with modulated electrohyperthermia and oncolytic virus injections?
  3. P. Hamar: Differential effects of modulated electro-hyperthermia on slow and fast progressing triple negative breast cancers and the effects of treatment protocol
  4. O. Szasz: Molecular basis of modulated electro-hyperthermia combination with radio- and chemo-therapies
  5. G. Fórika: Elevated apoptosis and tumor stem cell destruction in a radioresistant pancreatic adenocarcinoma cell line when radiotherapy is combined with modulated electro-hyperthermia
  6. C. Minnaar: Effects of modulated electro-hyperthermia on disease control and 3 year disease-free survival in locally advanced cervical cancer patients: Preliminary results


  1. S. Van Gool: Modulated electrohyperthermia as part of immunogenic cell death treatment in pediatric neuro-oncology
  2. A. Karaszi: Modulated electro-hyperthermia as additional treatment option in oncology – feasibility study on quality-of-life, imaging and biomarkers to support treatment planning
  3. T. Vancsik: Modulated electro-hyperthermia promotes doxorubicin cytotoxicity in a C26 colorectal carcinoma cell line model
  4. C. Schvarcz: Short term treatment with modulated electro-hyperthermia in triple negative breast cancer bearing mice
  5. L. Danics: Repeated treatment with modulated electro-hyperthermia inhibits tumor growth in a triple negative mouse breast cancer mode
  • Dr. Carrie Minnaar

  • Dr. Szász Olivér during his presentation

  • Oncotherm booth

Skip to content